litlas
ログインアカウント作成

Jorma Isola

1989–2025 年に発表

148
論文数
27,733
被引用数
92
h 指数
141
i10 指数

被引用数

Jorma Isola の年別被引用数1981 年: 被引用 1 件1990 年: 被引用 4 件1991 年: 被引用 2 件1992 年: 被引用 5 件1993 年: 被引用 14 件1994 年: 被引用 38 件1995 年: 被引用 50 件1996 年: 被引用 46 件1997 年: 被引用 119 件1998 年: 被引用 133 件1999 年: 被引用 205 件2000 年: 被引用 222 件2001 年: 被引用 212 件2002 年: 被引用 239 件2003 年: 被引用 271 件2004 年: 被引用 282 件2005 年: 被引用 273 件2006 年: 被引用 311 件2007 年: 被引用 312 件2008 年: 被引用 346 件2009 年: 被引用 338 件2010 年: 被引用 327 件2011 年: 被引用 312 件2012 年: 被引用 226 件2013 年: 被引用 271 件2014 年: 被引用 241 件2015 年: 被引用 183 件2016 年: 被引用 189 件2017 年: 被引用 206 件2018 年: 被引用 137 件2019 年: 被引用 436 件2020 年: 被引用 466 件2021 年: 被引用 479 件2022 年: 被引用 352 件2023 年: 被引用 280 件2024 年: 被引用 397 件2025 年: 被引用 226 件2026 年: 被引用 10 件1982〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,976 件、この内訳の 29.3%イギリス: 引用元論文 737 件、この内訳の 7.3%中国: 引用元論文 612 件、この内訳の 6%ドイツ: 引用元論文 510 件、この内訳の 5%フィンランド: 引用元論文 447 件、この内訳の 4.4%カナダ: 引用元論文 420 件、この内訳の 4.1%イタリア: 引用元論文 411 件、この内訳の 4%フランス: 引用元論文 348 件、この内訳の 3.4%日本: 引用元論文 301 件、この内訳の 3%オランダ: 引用元論文 290 件、この内訳の 2.9%オーストラリア: 引用元論文 272 件、この内訳の 2.7%スウェーデン: 引用元論文 241 件、この内訳の 2.4%
0%29.3%その他 25.5%

機関

分野

  • Medicine52.8%
  • Biochemistry, Genetics and Molecular Biology36.9%
  • Computer Science5.5%
  • Immunology and Microbiology1.5%
  • Neuroscience1%
  • Engineering0.5%
  • その他1.8%

トピック

  • HER2/EGFR in Cancer Research7.2%
  • Breast Cancer Treatment Studies4.2%
  • Monoclonal and Polyclonal Antibodies Research3.3%
  • Prostate Cancer Treatment and Research3.1%
  • Estrogen and related hormone effects2.4%
  • Cancer Genomics and Diagnostics2.3%
  • その他77.5%

共著者

全論文

検索で開く
  1. Trastuzumab emtansine: mechanisms of action and drug resistance

    著者: Márk Barok, Heikki Joensuu, Jorma Isola - Breast Cancer Research 2014 被引用: 585

  2. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease

    著者: Detlef Schuppan, Markku Mäki, Knut E. A. Lundin, Jorma Isola, Tina Friesing-Sosnik, Juha Taavela, Alina Popp, Jari Koskenpato, Jost Langhorst, Øistein Hovde, Marja‐Leena Lähdeaho, Stefano Fusco, Michael Schümann, Helga‐Paula Török, Juozas Kupčinskas, Yurdagül Zopf, Ansgar W. Lohse, Mika Scheinin, Karin Kull, Luc Biedermann, Valerie Byrnes, Andreas Stallmach, Jørgen Jahnsen, Jonas Zeitz, Ralf Mohrbacher, Roland Greinwald - New England Journal of Medicine 2021 被引用: 229

  3. A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

    著者: Vadim Le Joncour, Ana Martins, Maija Puhka, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen, Heikki Joensuu, Márk Barok - Molecular Cancer Therapeutics 2019 被引用: 85

  4. ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer

    著者: Márk Barok, Vadim Le Joncour, Ana Martins, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen, Heikki Joensuu - Cancer Letters 2020 被引用: 82

  5. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study

    著者: Marja‐Leena Lähdeaho, Mika Scheinin, Pekka Vuotikka, Juha Taavela, Alina Popp, Johanna Laukkarinen, Jukka Koffert, Olli‐Pekka Koivurova, Marko Pesu, Laura Kivelä, Zsófia Lovró, Joni Keisala, Jorma Isola, Jane R. Parnes, Francisco León, Markku Mäki - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 120

  6. Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line

    著者: Péter Nagy, Elza Friedländer, Minna Tanner, Anita I. Kapanen, Kermit L. Carraway, Jorma Isola, Thomas M. Jovin - Cancer Research 2005 被引用: 513

  7. Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy

    著者: Dmitrii Bychkov, Nina Linder, Aleksei Tiulpin, Hakan Kücükel, Mikael Lundin, Stig Nordling, Harri Sihto, Jorma Isola, Tiina Lehtimäki, Pirkko‐Liisa Kellokumpu‐Lehtinen, Karl von Smitten, Heikki Joensuu, Johan Lundin - Scientific Reports 2021 被引用: 75

  8. In vivo amplification of the androgen receptor gene and progression of human prostate cancer

    著者: Tapio Visakorpi, Eija Hyytinen, Pasi A. Koivisto, Minna Tanner, Riitta Keinänen, Christian Palmberg, Aarno Palotie, Teuvo L.J. Tammela, Jorma Isola, Olli Kallioniemi - Nature Genetics 1995 被引用: 1,486

  9. Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge

    著者: Joseph A. Murray, Jack A. Syage, Tsung‐Teh Wu, Matthew A. Dickason, Ana G. Ramos, Carol Van Dyke, Irina Horwath, Philip T. Lavin, Markku Mäki, Isabel A. Hujoel, Konstantinos A. Papadakis, Adam C. Bledsoe, Chaitan Khosla, Jennifer A. Sealey‐Voyksner, Chad Hinson, Vasiliy Loskutov, Anna Norum, Steven E. Linberg, Lawrence Goldkind, Jorma Isola, Robert D. Voyksner, Pauline Luong, Matthew R. Baldwin, J. Nezzer - Gastroenterology 2022 被引用: 73

  10. Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo

    著者: Márk Barok, Minna Tanner, Katri Köninki, Jorma Isola - Breast Cancer Research 2011 被引用: 233

  11. Breast cancer outcome prediction with tumour tissue images and machine learning

    著者: Riku Turkki, Dmitrii Byckhov, Mikael Lundin, Jorma Isola, Stig Nordling, Panu E. Kovanen, Clare Verrill, Karl von Smitten, Heikki Joensuu, Johan Lundin, Nina Linder - Breast Cancer Research and Treatment 2019 被引用: 133

  12. Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

    著者: Jason A. Tye–Din, A. James M. Daveson, Gautam Goel, Kaela E. Goldstein, Holly L. Hand, Kristin D. Neff, Alina Popp, Juha Taavela, Markku Mäki, Jorma Isola, Leslie Williams, Kenneth E. Truitt, Robert P. Anderson, Atoya Adams, Jane M. Andrews, C. Behrend, Gregor J. Brown, Swee Lin Chen Yi Mei, Allan Coates, Anthony J. DiMarino, Hooi C. Ee, David E. Elliott, ROGER M. EPSTEIN, Bryan John Feyen, Ronald P Fogel, Keith Friedenberg, Richard B. Gearry, Michael S Gerdis, Michael J. Goldstein, Vipin Gupta, Robert Holmes, Gerald J Holtmann, Samuel H Idarraga, G. James, Tim King, Terry D Klein, Sonia S. Kupfer, Benjamin Lebwohl, Matthew John Lowe, Joseph A. Murray, Eric Newton, Dean Quinn, David M Radin, Timothy E. Ritter, Helen Lee Stacey, Cynthia Strout, Richard S. Stubbs, Susan Lynn Thackwray, Vivek M Trivedi, John R Weber, Scott Wilson - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 34

  13. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67

    著者: Vilppu J. Tuominen, Sanna Ruotoistenmäki, Arttu Viitanen, Mervi Jumppanen, Jorma Isola - Breast Cancer Research 2010 被引用: 469

  14. Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease

    著者: Valeriia Dotsenko, Bernhard Tewes, Martin Hils, Ralf Pasternack, Jorma Isola, Juha Taavela, Alina Popp, Jani Sarin, Heini Huhtala, Pauliina Hiltunen, Timo Zimmermann, Ralf Mohrbacher, Roland Greinwald, Knut E. A. Lundin, Detlef Schuppan, Markku Mäki, Keijo Viiri, CEC-3 Investigators, Karin Kull, Jari Koskenpato, Mika Scheinin, Marja‐Leena Lähdeaho, Michael Schümann, Yurdagül Zopf, Andreas Stallmach, Ansgar W. Lohse, Stefano Fusco, Jost Langhorst, Helga‐Paula Török, Valerie Byrnes, Juozas Kupčinskas, Øistein Hovde, Jørgen Jahnsen, Luc Biedermann, Jonas Zeitz - Nature Immunology 2024 被引用: 45

  15. Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation

    著者: Márk Barok, Maija Puhka, György Vereb, János Szöllõsi, Jorma Isola, Heikki Joensuu - BMC Cancer 2018 被引用: 81

  16. Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge

    著者: Valeriia Dotsenko, Mikko Oittinen, Juha Taavela, Alina Popp, Markku Peräaho, Synnöve Staff, Jani Sarin, Francisco León, Jorma Isola, Markku Mäki, Keijo Viiri - Cellular and Molecular Gastroenterology and Hepatology 2020 被引用: 75

  17. Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer

    著者: Márk Barok, Minna Tanner, Katri Köninki, Jorma Isola - Cancer Letters 2011 被引用: 155

  18. The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment

    著者: Jorma Isola, Markku Mäki, Martin Hils, Ralf Pasternack, Keijo Viiri, Valeriia Dotsenko, Toni Montonen, Timo Zimmermann, Ralf Mohrbacher, Roland Greinwald, Detlef Schuppan - International Journal of Molecular Sciences 2023 被引用: 23

  19. Elevated Levels of StAR-Related Lipid Transfer Protein 3 Alter Cholesterol Balance and Adhesiveness of Breast Cancer Cells

    著者: Boris Vassilev, Harri Sihto, Shiqian Li, Maarit Hölttä‐Vuori, Jaakko Ilola, Johan Lundin, Jorma Isola, Pirkko‐Liisa Kellokumpu‐Lehtinen, Heikki Joensuu, Elina Ikonen - American Journal Of Pathology 2015 被引用: 85

  20. Inherited susceptibility to uterine leiomyomas and renal cell cancer

    著者: Virpi Launonen, Outi Vierimaa, Maija Kiuru, Jorma Isola, Stina Roth, ­Eero Pukkala, Pertti Sistonen, Riitta Herva, Lauri A. Aaltonen - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 被引用: 672

  21. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

    著者: Minna Tanner, Maija Hollmén, Teemu T. Junttila, Anita I. Kapanen, Satu Tommola, Ylermi Soini, Heikki Helin, Jarmo Salo, Heikki Joensuu, Eero Sihvo, Klaus Elenius, Jorma Isola - Annals of Oncology 2005 被引用: 664

  22. Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer

    著者: Zsuzsanna Pályi‐Krekk, Márk Barok, Jorma Isola, Markku Tammi, János Szöllo ̋si, Péter Nagy - European Journal of Cancer 2007 被引用: 145

  23. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

    著者: Lao H. Saal, Peter A. Johansson, Karolina Holm, Sofia K. Gruvberger-Saal, Qing‐Bai She, Matthew Maurer, Susan Koujak, Adolfo A. Ferrando, Per Malmström, Lorenzo Memeo, Jorma Isola, Pär‐Ola Bendahl, Neal Rosen, Hanina Hibshoosh, Markus Ringnér, Åke Borg, Ramon Parsons - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 被引用: 521

  24. Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer

    著者: Minna Tanner, Anita I. Kapanen, Teemu T. Junttila, Olayinka Raheem, Seija Grénman, Jussi P. Elo, Klaus Elenius, Jorma Isola - Molecular Cancer Therapeutics 2004 被引用: 269